The trials were halted after one study participant in the U.K. developed a neurological condition.
Testing sites in the U.S., which aim to enroll 30,000 people, were put on hold, as well as sites in Brazil and Europe.for clinical trials to pause because of unexpected adverse events.
During an online event Thursday morning, AstraZeneca's chief executive, Pascal Soriot, addressed public scrutiny of the clinical trial process. "The difference with other vaccines trials is the whole world is not watching them," Soriot said. He added that it's possible the company will have adequate safety and efficacy data on the vaccine by the end of this year, as long as a monitoring committee allows the company to resume the trial."You don't want to put anybody else at risk until you've sorted out the data.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Halted coronavirus vaccine study shows 'no compromises' on safety, NIH saysAstraZeneca's suspension of testing of its coronavirus vaccine while it investigates an illness shows there will be 'no compromises' on safety, the NIH chief said.
Weiterlesen »
U.S. NIH director says will not compromise on coronavirus vaccine safetyThe pause of AstraZeneca Plc's coronavirus vaccine trials due to an unexplained illness in a study participant shows that safety of vaccines will not be compromised, the head of the National Institutes of Health told a U.S. Congress panel on Wednesday.
Weiterlesen »
Trump's warp speed COVID vaccine plan hits snag as AstraZeneca pauses trialPhase 3 trials for AstraZeneca's COVID-19 vaccine candidate were paused Tuesday due to a 'potentially unexplained illness in one of the trials.'
Weiterlesen »
Collins and Adams face Senate health panelTwo top health officials are testifying this morning on vaccine progress in front of the Senate's health committee
Weiterlesen »
AstraZeneca Pauses Covid-19 Vaccine Trial After Illness in a U.K. SubjectAstraZeneca said it paused clinical trials of an experimental Covid-19 vaccine after a participant in a U.K. study had an unexplained illness.
Weiterlesen »
AstraZeneca COVID-19 vaccine tests paused after participant becomes illStudies of AstraZeneca’s COVID-19 vaccine candidate are on hold while the company investigates whether a recipient’s illness is a side effect of the shot.
Weiterlesen »